Increased levels of <scp>microRNA</scp>‐320 in blood serum and plasma is associated with imminent and advanced lung cancer
Therese Haugdahl Nøst(UiT The Arctic University of Norway), Pål Sætrom(Norwegian University of Science and Technology), Torkjel M. Sandanger(UiT The Arctic University of Norway), Oluf Dimitri Røe(Norwegian University of Science and Technology), Tom Dønnem(University Hospital of North Norway), Sigve Andersen(University Hospital of North Norway), Mattias Johansson(Centre international de recherche sur le cancer), Erna‐Elise Paulsen(University Hospital of North Norway), Robin Mjelle(Norwegian University of Science and Technology), Bjørn Henning Grønberg(Norwegian University of Science and Technology), Maria Markaki(University of Crete), Ilona Urbárová(UiT The Arctic University of Norway), Mikael Johansson(Centre international de recherche sur le cancer), Anne Heidi Skogholt(Norwegian University of Science and Technology)
Cited by 9
Related Papers
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use
|Nature Genetics|2019|2.2k
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
|Nature Genetics|2017|804
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
|PLoS ONE|2017|668